CPD-002, a novel VEGFR2 inhibitor, relieves rheumatoid arthritis by reducing angiogenesis through the suppression of the VEGFR2/PI3K/AKT signaling pathway
Fei Jiang, Mengqing Wang, Manyu Zhang, Sheng-long Gu, Yawen Xie, Yan Huang, Meng‐yuan Zhou, Feilong Li, Yu‐Chen S. H. Yang, Peipei Zhang, Xuesong Liu, Rong Li, Rong Li
Topics & Concepts
AngiogenesisRheumatoid arthritisProtein kinase BVEGF receptorsPI3K/AKT/mTOR pathwayMedicineCancer researchSignal transductionPharmacologyChemistryImmunologyBiochemistryAngiogenesis and VEGF in CancerPI3K/AKT/mTOR signaling in cancerNatural Compounds in Disease Treatment